Aminoguanidine prevents ototoxicity induced by cisplatin in rats

Annals of Clinical and Laboratory Science

Volumn 35, Issue 3, 2005, Pages 329-335

  Iraz, Mustafa ^a   Kalcioglu, M Tayyar ^a   Kizilay, Ahmet ^a   Karatas, Erkan ^b  

^a INONU UNIVERSITY   (Turkey)

^{b *}

Author keywords

Aminoguanidine; Cisplatin; Otoacoustic emissions; Ototoxicity

Indexed keywords

AMINOGUANIDINE; ANTINEOPLASTIC AGENT; CISPLATIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DETERIORATION; DISTORTION PRODUCT OTOACOUSTIC EMISSION; DRUG POTENCY; EAR PROTECTION; FEMALE; HEARING LOSS; INNER EAR DISEASE; LOW DRUG DOSE; NONHUMAN; OTOACOUSTIC EMISSION; OTOTOXICITY; PRIORITY JOURNAL; RAT;

ANIMALS; CISPLATIN; FEMALE; GUANIDINES; HEARING LOSS; OTOACOUSTIC EMISSIONS, SPONTANEOUS; RATS; RATS, WISTAR;

ANIMALIA;

EID: 23844446045     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Li Y, Womer RB, Silber JH. Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose. Eur J Cancer 2004;40:2445-2451.
2. Sluyter S, Klis SF, de Groot JC, Smoorenburg GF. Alterations in the stria vascularis in relation to cisplatin ototoxicity and recovery. Hear Res 2003;185:49-56.
3. Sockalingam R, Freeman S, Cherny TL, Sohmer H. Effect of high-dose cisplatin on auditory brainstem responses and otoacoustic emissions in laboratory animals. Am J Otol 2000;21:521-527.
4. Tampakopoulou DA, Sie KC. Cisplatin ototoxicity in developing gerbils. Hear Res 1999;132:51-59.
5. Rybak LP, Ravi R, Somani SM. Mechanism of protection by diethyldithiocarbamate against cisplatin ototoxicity: antioxidant system. Fundam Appl Toxicol 1995;26:293-300.
6. Masters BS, McMillan K, Sheta EA, Nishimura JS, Roman LJ, Martasek P. Neuronal nitric oxide synthase, a modular enzyme formed by convergent evolution: structure studies of a cysteine thiolate-liganded heme protein that hydroxylates L-arginine to produce NO as a cellular signal. FASEB J 1996;10:552-558.
7. 2+-dependently converts L-arginine into an activator of soluble guanylyl cyclase. Biochem Biophys Res Commun 1989;164:678-685.
8. Hess A, Bloch W, Huverstuhl J, Su J, Stennert E, Addicks K, Michel O. Expression of inducible nitric oxide synthase (iNOS/NOS II) in the cochlea of guinea pigs after intra-tympanical endotoxin-treatment Brain Res. 1999;830: 113-122.
9. Fessenden JD, Coling DE, Schacht J. Detection and characterization of nitric oxide synthase in the mammalian cochlea. Brain Res 1994;668:9-15.
10. Zdanski CJ, Carrasco V, Johnson K, Prazma J, Pillsbury HC. Inhibition of nitric oxide synthase causes elevation of hearing thresholds. Otolaryngol Head Neck Surg 1998;119:159-163.
11. Ren T, Nuttall AL, Miller JM. ATP-induced cochlear blood flow changes involve the nitric oxide pathway. Hear Res 1997;112:87-94.
12. Lopez-Gonzalez MA, Guerrero JM, Rojas F, Delgado F. Ototoxicity caused by cisplatin is ameliorated by melatonin and other antioxidants. J Pineal Res 2000;28: 73-80.
13. Rybak LP, Whitworth C, Somani S. Application of antioxidants and other agents to prevent cisplatin ototoxicity. Laryngoscope 1999;109:1740-1744.
14. Kizilay A, Kalcioglu MT, Ozerol E, Iraz M, Gulec M, Akyol O, Ozturan O. Caffeic acid phenethyl ester ameliorated ototoxicity induced by cisplatin in rats. J Chemother 2004;16:381-387.
15. Whitworth CA, Ramkumar V, Jones B, Tsukasaki N, Rybak LP. Protection against cisplatin ototoxicity by adenosine agonists. Biochem Pharmacol 2004;67:1801-1807.
16. Kalcioglu MT, Kizilay A, Gulec M, Karatas E, Iraz M, Akyol O, Egri M, Ozturan O. The protective effect of erdosteine against ototoxicity induced by cisplatin in rats. Eur Arch Otorhinolaryngol 2005 (in press).
17. Misko TP, Moore WM, Kasten TP, Nickols GA, Corbett JA, Tilton RG, McDaniel ML, Williamson JR, Currie MG. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol 1993;233:119-125.
18. Kelly TC, Whitworth CA, Husain K, Rybak LP. Amino-guanidine reduces cisplatin ototoxicity. Hear Res 2003;186:10-16.
19. Minami SB, Sha SH, Schacht J. Antioxidant protection in a new animal model of cisplatin-induced ototoxicity. Hear Res 2004;198:137-143.
20. Ekborn A, Laurell G, Ehrsson H, Miller J. Intracochlear administration of thiourea protects against cisplatin-induced outer hair cell loss in the guinea pig. Hear Res 2003;181:109-115.
21. Campbell KCM, Rybak LP, Meech RP, Hughes L. D-metionine provides excellent protection from cisplatin ototoxicity in the rat. Hear Res 1996;102:90-98.
22. Ravi R, Somani SM, Rybak LP. Mechanism of cisplatin ototoxicity: antioxidant system. Pharmacol Toxicol 1995;76:386-394.
23. Kopke RD, Liu W, Gabaizadeh R, Jacono A, Feghali J, Spray D, Garcia P, Steinman H, Malgrange B, Ruben RJ, Rybak L, Van de Water TR. Use of organotypic cultures of Corti's organ to study the protective effects of antioxidants molecules on cisplatin-induced damage of auditory hair cells. Am J Otol 1997;18:559-571.
24. Gosepath K, Gath I, Maurer J, Pollock JS, Amedee R, Forstermann U, Mann W. Characterization of nitric oxide synthase isoforms expressed in different structures of the guinea pig cochlea. Brain Res 1997;747:26-33.
25. Vass Z, Brechtelsbauer PB, Nuttall AL, Miller JM. Nitric oxide mediates capsaicin-induced increase in cochlear blood flow. Hear Res 1996;100:114-119.
26. Raman CS, Li H, Martasek P, Southan G, Masters BS, Poulos TL. Crystal structure of nitric oxide synthase bound to nitro indazoic reveals a novel inactivation mechanism. Biochemistry 2001;40:13448-13455.
27. Takumida M, Anniko M. Nitric oxide in guinea pig vestibular sensory cells following gentamicin exposure in vitro. Acta Otolaryngol 2001;121:346-550.
28. Watanabe K, Inai S, Jinnoucbi K, Bada S, Hess A, Michel O, Yagi T. Nuclear-factor kappa B (NF-kappa B)-inducible nitric oxide synthase (iNOS/NOS II) pathway damages the stria vascularis in cisplatin-treated mice. Anticancer Res 2002;22:4081-4085.
29. Watanabe K, Tomiyama S, Jinnouchi K, Hess A, Michel O, Yagi T. Expression of inducible nitric oxide synthase (iNOS/NOS II) in the hydropic vestibule after injection of keyhole limpet hemocyanin into the endolymphatic sac of guinea pigs. J Vestib Res 2001;11:67-71.
30. Watanabe K, Tomiyama S, Jinnouchi K, Yagi T. Apoptosis in the hydropic cochlea of guinea pigs following immune reaction of the endolymphatic sac: immunohistochemical analysis. Eur Arch Otorhinolaryngol 2001;258:296-299.
31. Watanabe KI, Hess A, Bloch W, Michel O. Nitric oxide synthase inhibitor suppresses the ototoxic side effect of cisplatin in guinea pigs. Anticancer Drugs 2000;11:401-406.
32. Kalkanis JG, Whitworth C, Rybak LP. Vitamin E reduces cisplatin ototoxicity. Laryngoscope 2004;114:538-542.
33. Thomas Dickey D, Muldoon LL, Kraemer DF, Neuwelt EA. Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model. Hear Res 2004;193:25-30.
34. Sergi B, Ferraresi A, Troiani D, Paludetti G, Fetoni AR. Cisplatin ototoxicity in the guinea pig: vestibular and cochlear damage. Hear Res 2003;182:56-64.
35. Mansour MA, Mostafa AM, Nagi MN, Khattab MM, Al-Shabanah OA. Protective effect of aminoguanidine against nephrotoxicity induced by cisplatin in normal rats. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 2002;132:123-128.
36. Muijsers RB, Folkerts G, Henricks PA, Sadeghi-Hashjin G, Nijkamp FP. Peroxynitrite: a two-faced metabolite of nitric oxide. Life Sci. 1997;60:1833-1845.
37. Yildirim Z, Turkoz Y, Kotuk M, Armutcu F, Gurel A, Iraz M, Ozen S, Aydogdu I, Akyol O. Effects of aminoguanidine and antioxidant erdosteine on bleomycin-induced lung fibrosis in rats. Nitric Oxide 2004;11:156-165.
38. Tabuchi K, Tsuji S, Asaka Y, Hara A, Kusakari J. Ischemia-reperfusion injury of the cochlea: effects of an iron chelator and nitric oxide synthase inhibitors. Hear Res 2001;160:31-36.
39. Ruan RS. Possible roles of nitric oxide in the physiology and pathophysiology of the mammalian cochlea. Ann N Y Acad Sci 2002;962:260-274.
40. Stengs CH, Klis SF, Huizing EH, Smoorenburg GF. Cisplatin-induced ototoxicity; electrophysiological evidence of spontaneous recovery in the albino guinea pig. Hear Res 1997;111:103-113.